Pages that link to "Item:Q3749986"
From MaRDI portal
The following pages link to Approximately Optimal One-Parameter Boundaries for Group Sequential Trials (Q3749986):
Displaying 40 items.
- A hybrid geometric phase II/III clinical trial design based on treatment failure time and toxicity (Q665054) (← links)
- Group sequential designs for one-sided and two-sided hypothesis testing with provision for early stopping in favor of the null hypothesis (Q1338348) (← links)
- Basic concepts of group sequential and adaptive group sequential test procedures (Q1580842) (← links)
- Control of type I error rates in Bayesian sequential designs (Q1738139) (← links)
- Refined critical boundary with enhanced statistical power for non-directional two-sided tests in group sequential designs with multiple endpoints (Q2065275) (← links)
- Asymptotically optimal multistage tests of simple hypotheses (Q2466684) (← links)
- Odds ratio-based group sequential analysis for joint binomial and inverse binomial sampling (Q2816633) (← links)
- Asymmetric Group Sequential Designs under Fractional Brownian Motion (Q2839077) (← links)
- Adaptive designs with arbitrary dependence structure (Q2874295) (← links)
- An evaluation of inferential procedures for adaptive clinical trial designs with pre-specified rules for modifying the sample size (Q2927605) (← links)
- Computation of optimal group sequential designs (Q2958399) (← links)
- Combining an Internal Pilot with an Interim Analysis for Single Degree of Freedom Tests (Q3064104) (← links)
- Testing a Primary and a Secondary Endpoint in a Group Sequential Design (Q3076047) (← links)
- Adaptive Group Sequential Designs for Clinical Trials: Combining the Advantages of Adaptive and of Classical Group Sequential Approaches (Q3078835) (← links)
- A Simple Algorithm for Designing Group Sequential Clinical Trials (Q3078849) (← links)
- Pivotal Quantities Based on Sequential Data: A Bootstrap Approach (Q3424310) (← links)
- Optimal Conditional Error Functions for the Control of Conditional Power (Q3445294) (← links)
- Exact Confidence Bounds Following Adaptive Group Sequential Tests (Q3637002) (← links)
- Approximately Optimal Continuous Stopping Boundaries in a One-Sided Standard Sequential Test (Q3652763) (← links)
- Data-Driven Analysis Strategies for Proportion Studies in Adaptive Group Sequential Test Designs (Q4430337) (← links)
- A New Interim Monitoring Statistic for Group Sequential Clinical Trials (Q4449151) (← links)
- A Shift Algorithm for Exact Computation in Sequential Tests with Binary Outcome (Q4488929) (← links)
- A Unifying Family of Group Sequential Test Designs (Q4666661) (← links)
- Adaptive Sample Size Calculations in Group Sequential Trials (Q4668352) (← links)
- Designing one-sided group sequential clinical trials to detect a mixture alternative (Q4689948) (← links)
- CONDITIONAL PROBABILITY OF SIGNIFICANCE FOR EARLY STOPPING IN FAVOR OF<i>H</i><sub>0</sub> (Q4787882) (← links)
- Optimal two-sided group sequential tests (Q4865167) (← links)
- Optimal group sequential designs constrained on both overall and stage one error rates (Q5077869) (← links)
- Optimal Stopping Rules for Sequential Hypothesis Testing (Q5111719) (← links)
- Unbalanced and Partial Group Sequential Methods for Normal Responses in Clinical Trials (Q5413549) (← links)
- <i>p</i>-Value calculation for multi-stage additive tests (Q5454212) (← links)
- Weighted Logrank Statistics in Sequential Tests (Q5458030) (← links)
- On group sequential tests for data in unequally sized groups and with unknown variance (Q5939504) (← links)
- Optimization of adaptive designs with respect to a performance score (Q6068637) (← links)
- Point estimation, confidence intervals, and \(P\)-values for optimal adaptive two-stage designs with normal endpoints (Q6618447) (← links)
- Asymptotically optimal multistage tests for non-i.i.d. data (Q6621338) (← links)
- On the efficiency of adaptive sample size design (Q6625705) (← links)
- The person-time ratio distribution for the exact monitoring of adverse events: historical vs surveillance Poisson data (Q6626852) (← links)
- Exact sequential test for clinical trials and post-market drug and vaccine safety surveillance with Poisson and binary data (Q6627990) (← links)
- An additive boundary for group sequential designs with connection to conditional error (Q6628724) (← links)
